ACTRN12615001265561招募中1 期
In patients with Non-Small Cell Lung Cancer (NSCLC) is Pentixafor-PET a more accurate imaging test than FDG-PET for local staging and identifying sites of metastatic disease?
Oceanic Molecular Imaging0 个研究点目标入组 30 人开始时间: 2015年11月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 40 Years 至 o limit（—）
- 性别
- All
入选标准
- •a.Histological diagnosis of NSCLC.
- •b.Requires 18F-FDG PET/CT as part of routine work-up for diagnosis and staging.
- •c.Competent to provide informed consent
- •d.Not pregnant or breastfeeding
排除标准
- •Pregnant or breastfeeding
- •Lack of indication or contraindication to FDG PET
研究者
相似试验
已完成
不适用
tritional Assessment in Non-small Cell lung cancer patientslungcancerNon Small Cell Lung Cancer10038666NL-OMON50451Antoni van Leeuwenhoek Ziekenhuis100
已完成
不适用
Benefits of home-based multidisciplinaryrehabilitation in non small cell lung canceron small cell lung cancerNon small cell lung cancerCancer - Lung - Non small cellPhysical Medicine / Rehabilitation - PhysiotherapyACTRN12614001268639Professor Linda Denehy92
已完成
不适用
Prognostic factors of non-small cell lung cancer patients with brain metastasison-small cell lung cancerJPRN-UMIN000030313KKR Sapporo Medical Center300
已完成
不适用
Supportive treatment in non-small cell lung canceron small cell lung cancerNon small cell lung cancerCancerISRCTN96733516Medical Research Council (MRC) (UK)230
暂停
3 期
EGF vaccine- Advanced Lung tumorson Small Cells Lung CancerRPCEC00000161Centre of Molecular Immunology (CIM)579